Globalspace Technologies IPO vs Vaishali Pharma IPO

Comparison between Globalspace Technologies IPO and Vaishali Pharma IPO.

IPO Details

Globalspace Technologies IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Vaishali Pharma IPO is a SME Bookbuilding proposed to list at NSE SME.

Issue Size and Price

The total issue size of Globalspace Technologies IPO is up to ₹19.01 Cr whereas the issue size of the Vaishali Pharma IPO is up to ₹13.48 Cr. The final issue price of Globalspace Technologies IPO is ₹66.00 per share and of Vaishali Pharma IPO is ₹72.00 per share.

 Globalspace Technologies IPOVaishali Pharma IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹71.00 per share
Issue Price (Upper)₹72.00 per share
Issue Price (Final)₹66.00 per share₹72.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size2000 shares1600 shares
Fresh Issue Size28,80,000 shares18,72,000 shares
Fresh Issue Size (Amount)up to ₹19.01 Crup to ₹13.48 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total28,80,000 shares18,72,000 shares
Issue Size Total (Amount)up to ₹19.01 Crup to ₹13.48 Cr

IPO Timetable

Globalspace Technologies IPO opens on Jul 26, 2017, while Vaishali Pharma IPO opens on Aug 07, 2017. The closing date of Globalspace Technologies IPO and Vaishali Pharma IPO is Jul 28, 2017, and Aug 10, 2017, respectively.

 Globalspace Technologies IPOVaishali Pharma IPO
Issue OpenJul 26, 2017Aug 07, 2017
Issue CloseJul 28, 2017Aug 10, 2017
Basis Of Allotment (Tentative)Aug 02, 2017Aug 16, 2017
Listing date (Tentative)Aug 07, 2017Aug 22, 2017

Financials & KPIs

Globalspace Technologies IPO P/E ratio is , as compared to Vaishali Pharma IPO P/E ratio of .

 Globalspace Technologies IPOVaishali Pharma IPO
Financials

Company Financials (Restated)

Period Ended31 Mar 201731 Mar 201631 Mar 2015
Assets22.8916.4210.64
Total Income17.2813.9810.80
Profit After Tax1.020.620.85
NET Worth10.327.014.62
Reserves and Surplus1.895.853.67
Total Borrowing6.763.753.72
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Mar 201731 Mar 201631 Mar 2015
Assets44.6549.4145.80
Total Income67.1169.8998.82
Profit After Tax0.66-0.030.16
NET Worth3.873.203.24
Reserves and Surplus0.872.702.74
Total Borrowing21.1719.7624.04
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)75.22%100%
Promoter Shareholding (Post-Issue)55.30%70.02%
Market Cap₹75.61 Cr.₹47.46 Cr.

Shares Offered

In the Globalspace Technologies IPO Retail Individual Investors (RII) are offered 14,40,000 shares while in Vaishali Pharma IPO retail investors are offered 14,40,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Globalspace Technologies IPO and 0 shares in Vaishali Pharma IPO.

 Globalspace Technologies IPOVaishali Pharma IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation1,54,000 shares1,04,000 shares
QIB0 shares0 shares
NII14,40,000 shares9,36,000 shares
RII14,40,000 shares9,36,000 shares
Employee0 shares0 shares
Total28,80,000 shares18,72,000 shares

Bids Received (Subscription)

Globalspace Technologies IPO subscribed 1.56x in total, whereas Vaishali Pharma IPO subscribed 2.00x.

Compare with others

Compare:

Globalspace Technologies IPO Vs Vaishali Pharma IPO